Rapid screening of neuraminidase inhibitors using an at-line nanofractionation platform involving parallel oseltamivir-sensitive/resistant neuraminidase bioassays

J Chromatogr A. 2023 Jan 4:1687:463693. doi: 10.1016/j.chroma.2022.463693. Epub 2022 Nov 29.

Abstract

In this study, an advanced at-line nanofractionation based screening platform was developed to screen potential neuraminidase inhibitors (NAIs) from Lonicera japonica Thunb by involving two parallel bioassays, for determining both oseltamivir-sensitive neuraminidase (NAS) and oseltamivir-resistant neuraminidase (NAR) inhibitory activities. 20 potential NAIs with both NAS and NAR inhibitory effects were screened from Lonicera japonica Thunb and identified by mass spectrometer, including 11 phenolic acids, 8 flavonoids and one iridoid glycoside. The proposed at-line nanofractionation based screening platform for NAIs was also used to rapidly screen nine batches of water extracts of Lonicera japonica Thunb or its similar species. Clear differences in the number and content of active components were easily observed, demonstrating that the proposed method possesses great potential for the quality control of herb medicines.

Keywords: At-line nanofractionation; High-throughput screening; Lonicera japonica Thunb; Neuraminidase inhibitors; Parallel oseltamivir-sensitive/resistant neuraminidase bioassays.

MeSH terms

  • Antiviral Agents / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Guanidines / pharmacology
  • Influenza A Virus, H1N1 Subtype*
  • Lonicera*
  • Neuraminidase
  • Oseltamivir / pharmacology

Substances

  • Oseltamivir
  • Neuraminidase
  • Antiviral Agents
  • Enzyme Inhibitors
  • Guanidines